DermTech

DermTech, Inc. is a molecular diagnostic company based in La Jolla, California, focused on developing and marketing non-invasive diagnostic tests for skin cancer and related conditions in the United States. The company offers the Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and eliminates the need for surgical biopsies of atypical pigmented lesions. Additionally, DermTech provides the Nevome test, an adjunctive reflex test for the PLA, along with adhesive skin sample collection kits and gene expression assays targeting specific inflammatory pathways. The firm is also working on diagnostic products for non-melanoma skin cancer and risk assessment. DermTech generates revenue primarily by selling its products to pathology and oncology practitioners, and its assays are performed at a CLIA-certified laboratory in San Diego, utilizing adhesive tape biopsy methods to collect skin samples non-invasively.